{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:24:11Z","timestamp":1793222651716,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"The authors are grateful to The World Academy of Sciences for the Advancement of Science in Developing Countries (twas) awarded to Prof. Francis W. Muregi.","award":["11-082 RG\/BIO\/AF\/AC_I; UNESCO FR: 3240262705"],"award-info":[{"award-number":["11-082 RG\/BIO\/AF\/AC_I; UNESCO FR: 3240262705"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12936-017-1917-6","type":"journal-article","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T12:14:57Z","timestamp":1499084097000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse model"],"prefix":"10.1186","volume":"16","author":[{"given":"Onyango C.","family":"Odhiambo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah N.","family":"Wamakima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel N.","family":"Magoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Kirira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonface J.","family":"Malala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis T.","family":"Kimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3470-7445","authenticated-orcid":false,"given":"Francis W.","family":"Muregi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","volume":"14","author":"TNC Wells","year":"2015","unstructured":"Wells TNC, Van Huijsduijnen RH, Van Voorhis WC. Malaria medicines, a glass half full. Nat Rev Drug Discov. 2015;14:424\u20135.","journal-title":"Nat Rev Drug Discov"},{"key":"1917_CR2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2353\/ajpath.2010.091090","volume":"176","author":"MS Desruisseaux","year":"2010","unstructured":"Desruisseaux MS, Machado FS, Weiss LM, Tanowitz HB, Golightly LM. Cerebral malaria: a vasculopathy. Am J Pathol. 2010;176:1075\u20138.","journal-title":"Am J Pathol"},{"key":"1917_CR3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-7622-1-6","volume":"1","author":"NB Mock","year":"2004","unstructured":"Mock NB, Duale S, Brown LF, Elliott S, et al. Conflict and HIV, a framework for risk assessment to prevent HIV in conflict-affected settings in Africa. Emerg Themes Epidemiol. 2004;1:6.","journal-title":"Emerg Themes Epidemiol"},{"key":"1917_CR4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.2006-2027","volume":"119","author":"MJ Boivin","year":"2007","unstructured":"Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119:360\u20136.","journal-title":"Pediatrics"},{"key":"1917_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ardp.200700184","volume":"341","author":"M Schlitzer","year":"2008","unstructured":"Schlitzer M. Antimalarial drugs\u2014what is in use and what is in the pipeline. Arch Pharm (Weinheim). 2008;341:149\u201363.","journal-title":"Arch Pharm (Weinheim)"},{"key":"1917_CR6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","volume":"10","author":"J Achan","year":"2011","unstructured":"Achan J, Talisuna AO, Erhart A, Yeka A, Tibenderana JK, Baliraine FN, et al. Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria. Malar J. 2011;10:144.","journal-title":"Malar J"},{"key":"1917_CR7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.idc.2004.10.007","volume":"19","author":"G Pasvol","year":"2005","unstructured":"Pasvol G. Management of severe malaria: interventions and controversies. Infect Dis Clin North Am. 2005;19:211\u201340.","journal-title":"Infect Dis Clin North Am"},{"key":"1917_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1475-2875-9-97","volume":"9","author":"NH Phu","year":"2010","unstructured":"Phu NH, Tuan PQ, Day N, Mai NT, Chau TT, Chuong LV, et al. Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria. Malar J. 2010;9:97.","journal-title":"Malar J"},{"key":"1917_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1203\/PDR.0b013e3181eee738","volume":"68","author":"R Idro","year":"2010","unstructured":"Idro R, Marsh K, John CC, Newton CR. Mechanisms of brain injury and strategies for improved neuro-cognitive outcome. Pediatr Res. 2010;68:267\u201374.","journal-title":"Pediatr Res"},{"key":"1917_CR10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"1917_CR11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/clpt.2009.51","volume":"85","author":"P Olliaro","year":"2009","unstructured":"Olliaro P, Wells TN. The global portfolio of new antimalarial medicines under development. Clin Pharmacol Ther. 2009;85:584\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"1917_CR12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ddr.20345","volume":"71","author":"FW Muregi","year":"2010","unstructured":"Muregi FW, Ishih A. Next-generation antimalarial drugs: hybrid molecules as a new strategy in drug design. Drug Dev Res. 2010;71:20\u201332.","journal-title":"Drug Dev Res"},{"key":"1917_CR13","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1128\/AAC.00967-06","volume":"51","author":"F Benoit-Vical","year":"2007","unstructured":"Benoit-Vical F, Leli\u00e8vre J, Berry A, Deymier C, Dechy-Cabaret O, Cazelles J, et al. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes. Antimicrob Agents Chemother. 2007;51:1463\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"1917_CR14","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","volume":"48","author":"R Morphy","year":"2005","unstructured":"Morphy R, Rankovic Z. Designed multiple ligands: an emerging drug discovery paradigm. J Med Chem. 2005;48:6523.","journal-title":"J Med Chem"},{"key":"1917_CR15","first-page":"648","volume":"6","author":"F Grellepois","year":"2005","unstructured":"Grellepois F, Grellier P, Bonnet-Delpon D, B\u00e9gu\u00e9 J-P. Design, synthesis and antimalarial activity of trifluoromethylartemisinin-mefloquine dual molecules. Chem Biochem. 2005;6:648\u201352.","journal-title":"Chem Biochem"},{"key":"1917_CR16","doi-asserted-by":"crossref","first-page":"17579","DOI":"10.1073\/pnas.0804338105","volume":"105","author":"F Cosl\u00e9dan","year":"2008","unstructured":"Cosl\u00e9dan F, Fraisse L, Pellet A, Guillou F, Mordm\u00fcller B, Kremsner P, et al. Selection of a trioxaquine as an antimalarial drug candidate. Proc Natl Acad Sci USA. 2008;105:17579\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1917_CR17","unstructured":"Wamakima HN. Synthesis and antimalarial evaluation of a quinoline\u2013trioxane hybrid drug. Kenyatta University. Retrieved from Kenyatta University e-repository. 2015. http:\/\/etd-library.ku.ac.ke\/handle\/123456789\/13316 . Accessed 8 Apr 2017."},{"key":"1917_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12936-015-0550-5","volume":"14","author":"WR Gimode","year":"2015","unstructured":"Gimode WR, Kiboi DM, Kimani FT, Wamakima HN, Burugu MW, Muregi FW. Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model. Malar J. 2015;14:38.","journal-title":"Malar J"},{"key":"1917_CR19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1475-2875-13-116","volume":"13","author":"M Wang","year":"2014","unstructured":"Wang M, Feng Y, Pang W, Qi Z, Zhang Y, Guo YJ, et al. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei. Malar J. 2014;13:116.","journal-title":"Malar J"},{"key":"1917_CR20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1475-2875-10-330","volume":"10","author":"S Ghosh","year":"2011","unstructured":"Ghosh S, Sengupta A, Sharma S, Sonawat HM. Multivariate modelling with 1H NMR of pleural effusion in murine cerebral malaria. Malar J. 2011;10:330.","journal-title":"Malar J"},{"key":"1917_CR21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/00034983.1970.11686683","volume":"64","author":"JF Ryley","year":"1970","unstructured":"Ryley JF, Peters W. The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol. 1970;64:209\u201322.","journal-title":"Ann Trop Med Parasitol"},{"key":"1917_CR22","doi-asserted-by":"crossref","first-page":"e21251","DOI":"10.1371\/journal.pone.0021251","volume":"6","author":"FW Muregi","year":"2011","unstructured":"Muregi FW, Ohta I, Masato U, Kino H, Ishih A. Resistance of a rodent malaria parasite to a thymidylate synthase inhibitor induces an apoptotic parasite death and imposes a huge cost of fitness. PLoS ONE. 2011;6:e21251.","journal-title":"PLoS ONE"},{"key":"1917_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.18088\/ejbmr.2.1.2016.pp15-17","volume":"2","author":"Barbosa A Silva Da","year":"2016","unstructured":"Da Silva Barbosa A, Ferreira MES, dos Santos Carmo L, Green MD, Dolabela MF, Percario S. Evans blue staining for the assessment of blood\u2013brain barrier integrity in experimental malaria. Eur J Biomed Res. 2016;2:15\u20137.","journal-title":"Eur J Biomed Res"},{"key":"1917_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yrtph.2004.12.006","volume":"42","author":"E Schlede","year":"2005","unstructured":"Schlede E, Genschow E, Spielmann H, Stropp G, Kayser D. Oral acute toxic class method: a successful alternative to the oral LD 50 test. Regul Toxicol Pharmacol. 2005;42:15\u201323.","journal-title":"Regul Toxicol Pharmacol"},{"key":"1917_CR25","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1128\/AAC.00669-07","volume":"51","author":"JX Kelly","year":"2007","unstructured":"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, et al. Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum. Antimicrob Agents Chemother. 2007;51:4133\u201340.","journal-title":"Antimicrob Agents Chemother"},{"key":"1917_CR26","doi-asserted-by":"crossref","first-page":"e1004528","DOI":"10.1371\/journal.ppat.1004528","volume":"10","author":"A Nacer","year":"2014","unstructured":"Nacer A, Movila A, Sohet F, Girgis NM, Gundra UM, Loke P, et al. Experimental cerebral malaria pathogenesis\u2014hemodynamics at the blood brain barrier. PLoS Pathog. 2014;10:e1004528.","journal-title":"PLoS Pathog"},{"key":"1917_CR27","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1128\/IAI.00079-10","volume":"78","author":"FG Baptista","year":"2010","unstructured":"Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, Vigario AM. Accumulation of Plasmodium berghei-infected red blood cells in the brain are crucial for the development of cerebral malaria in mice. Infect Immun. 2010;78:4033\u20139.","journal-title":"Infect Immun"},{"key":"1917_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/intimm\/dxg065","volume":"15","author":"M Hayano","year":"2003","unstructured":"Hayano M, Kojima S, Hanum S. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol. 2003;15:633\u201340.","journal-title":"Int Immunol"},{"key":"1917_CR29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.01277-10","volume":"55","author":"L Clemmer","year":"2011","unstructured":"Clemmer L, Martins YC, Zanini GM, Frangos JA, Carvalho LJ. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain. Antimicrob Agents Chemother. 2011;55:1383\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"1917_CR30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.pt.2010.03.001","volume":"26","author":"LJ Carvalho","year":"2010","unstructured":"Carvalho LJ. Murine cerebral malaria: how far from human cerebral malaria? Trends Parasitol. 2010;26:271\u20132.","journal-title":"Trends Parasitol"},{"key":"1917_CR31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/0169-4758(94)90238-0","volume":"10","author":"AR Berendt","year":"1994","unstructured":"Berendt AR, Tumer GDH, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994;10:412\u20134.","journal-title":"Parasitol Today"},{"key":"1917_CR32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4161\/viru.19013","volume":"3","author":"L R\u00e9nia","year":"2012","unstructured":"R\u00e9nia L, Howland SW, Claser C, Gruner AC, Suwanarusk R, Hui T, et al. Cerebral malaria: mysteries at the blood\u2013brain barrier. Virulence. 2012;3:193\u2013201.","journal-title":"Virulence"},{"key":"1917_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1462-5822.2010.01528.x","volume":"13","author":"SC Wassmer","year":"2011","unstructured":"Wassmer SC, Moxon CA, Taylor T, Grau GE, Molyneux ME, Craig AG. Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF. Cell Microbiol. 2011;13:198\u2013209.","journal-title":"Cell Microbiol"},{"key":"1917_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1567202043480116","volume":"1","author":"N Coltel","year":"2004","unstructured":"Coltel N, Combes V, Hunt NH, Grau GE. Cerebral malaria\u2014a neurovascular pathology with many riddles still to be solved. Curr Neurovasc Res. 2004;1:91\u2013110.","journal-title":"Curr Neurovasc Res"},{"key":"1917_CR35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E. Astrocyte\u2013endothelial interactions at the blood\u2013brain barrier. Nat Rev Neurosci. 2006;7:41\u201353.","journal-title":"Nat Rev Neurosci"},{"key":"1917_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-8118-9-23","volume":"9","author":"A-C Luissint","year":"2012","unstructured":"Luissint A-C, Artus C, Glacial F, Ganeshamoorthy K, Couraud PO. Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation. Fluids Barriers CNS. 2012;9:23.","journal-title":"Fluids Barriers CNS"},{"key":"1917_CR37","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpara.2006.02.004","volume":"36","author":"IM Medana","year":"2006","unstructured":"Medana IM, Turner GD. Human cerebral malaria and the blood\u2013brain barrier. Int J Parasitol. 2006;36:555\u201368.","journal-title":"Int J Parasitol"},{"key":"1917_CR38","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/IAI.00810-10","volume":"79","author":"CN Morrell","year":"2011","unstructured":"Morrell CN, Srivastava K, Swaim A, Lee MT, Chen J, Nagineni C, et al. Beta interferon suppresses the development of experimental cerebral malaria. Infect Immun. 2011;79:1750\u20138.","journal-title":"Infect Immun"},{"key":"1917_CR39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3945\/ajcn.2009.28260","volume":"91","author":"MS Herbas","year":"2010","unstructured":"Herbas MS, Okazaki M, Terao E, Xuan X, Arai H, Suzuki H. \u03b1-Tocopherol transfer protein inhibition is effective in the prevention of cerebral malaria in mice. Am J Clin Nutr. 2010;91:200\u20137.","journal-title":"Am J Clin Nutr"},{"key":"1917_CR40","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1128\/IAI.01337-10","volume":"79","author":"T Tamura","year":"2011","unstructured":"Tamura T, Kimura K, Yuda M, Yui K. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Infect Immun. 2011;79:3947\u201356.","journal-title":"Infect Immun"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-017-1917-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T05:44:41Z","timestamp":1719294281000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-017-1917-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1186\/s12936-017-1917-6","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,3]]},"article-number":"268"}}